Adverse effects such as tachycardia, infections, headaches, dizziness, nausea, vomiting, diarrhea, and dyspepsia, as well as contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, hypersensitivity, severe gastrointestinal diseases, renal impairment, and pregnancy have been noted
Russell VA, Sagvolden T, Johansen EB
Each molecule is judged on depth of weight loss, durability of effect, the range of comorbidities it improves, and whether it arrives as a pill or an injection
The data used in this publication was provided by the Conticanet (Connective Tissue Cancer Network) database ( and the French sarcoma network RRePS ( These databases are financially supported by Conticanet and INCa (Institut National du Cancer)
Retatrutide has been studied in various areas of metabolic and physiological research